Record Backlog Strengthens Demand Story, But Execution Risks Keep LMT a Wait

What happened

Lockheed Martin reported Q3 2026 earnings, with management announcing a record backlog of $292 billion, up from $230.4 billion at the end of Q2, driven by continued strong missile and defense demand. The stock has been volatile amid broader market anxiety, but the record backlog provides substantial revenue visibility and reinforces the company's position as a prime defense contractor. However, the latest DeepValue master report cautioned that the stock already trades at 21.4x earnings and 19.5x EV/EBITDA, and execution issues like F-16 and C-130 charges persisted in Q2. The key questions remain whether funded PAC-3 awards materialize under final FY2026 appropriations and whether Missiles and Fire Control margins can sustain above 14% while Aeronautics stops absorbing new charges. Therefore, while the record backlog is encouraging, it does not eliminate the need for disciplined execution and funded order conversion to justify further upside from current levels.

Implication

The record backlog of $292 billion confirms robust demand, but the stock's valuation already embeds much of the missile growth story at 21.4x earnings and 19.5x EV/EBITDA. The master report's base case values LMT at $605, implying limited upside from the July 2026 price of $582.6, and the attractive entry level is $545. The critical catalysts for a more bullish stance are funded PAC-3 awards under final FY2026 appropriations and sustained MFC margins above 14%, which have not yet been confirmed. Additionally, Aeronautics must stop recording new profit adjustments on programs like F-16 and C-130, as these have eroded earnings in recent quarters. Until these conditions are met, investors should hold or wait for a pullback rather than add aggressively.

Thesis delta

The record backlog of $292 billion reinforces the demand thesis but does not fundamentally alter the uncertainty around execution and funded conversions. The investment thesis remains a WAIT, as the stock's valuation already incorporates much of the missile growth story, and the critical catalysts of funded PAC-3 awards and margin sustainability are still unproven. A shift to a more constructive stance would require evidence of these items in the next quarterly filings.